Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ufp Technologies (UFPT) Acquisitions (2018 - 2025)

Ufp Technologies posted quarterly Acquisitions of -$5000.0 for Q4 2025, down 100.48% year-on-year from $1.0 million in Q4 2024, and down 100.04% on a QoQ basis from $11.9 million in Q3 2025.

Ufp Technologies (UFPT) has 5 years of Acquisitions data on file, last reported at -$5000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Acquisitions fell 100.48% year-over-year to -$5000.0; the trailing twelve-month figure through Dec 2025 stood at $204.8 million (up 6.16% YoY), and the FY2025 full-year result was $14.7 million, down 92.54% from the prior year.
  • Acquisitions for Q4 2025 stood at -$5000.0, down from $11.9 million in the prior quarter.
  • Across five years, Acquisitions topped out at $191.8 million in Q3 2024 and bottomed at -$115000.0 in Q1 2022.
  • The 4-year median for Acquisitions is $6.5 million (2024), against an average of $40.2 million.
  • Peak annual rise in Acquisitions reached 93.8% in 2025, while the deepest fall reached 100.48% in 2025.
  • A 4-year view of Acquisitions shows it stood at $96.2 million in 2021, then slumped by 100.12% to -$115000.0 in 2022, then soared by 1008.7% to $1.0 million in 2024, then sank by 100.48% to -$5000.0 in 2025.
  • The last three Acquisitions figures came in at -$5000.0 (Q4 2025), $11.9 million (Q3 2025), and $1.0 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 22.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 523.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -268.10 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 2.30 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Ufp Technologies 1.69 Bn 1.67 Bn 44.36 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -5,000.00
Sep 30, 2025 11.89 Mn
Dec 31, 2024 1.05 Mn
Sep 30, 2024 191.82 Mn
Dec 31, 2022 -115,000.00
Sep 30, 2022 20.88 Mn
Mar 31, 2022 -115,000.00
Dec 31, 2021 96.18 Mn
Mar 31, 2018 76.98 Mn